Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Linn, Woelber"'
Autor:
Tim Mandelkow, Elena Bady, Magalie C. J. Lurati, Jonas B. Raedler, Jan H. Müller, Zhihao Huang, Eik Vettorazzi, Maximilian Lennartz, Till S. Clauditz, Patrick Lebok, Lisa Steinhilper, Linn Woelber, Guido Sauter, Enikö Berkes, Simon Bühler, Peter Paluchowski, Uwe Heilenkötter, Volkmar Müller, Barbara Schmalfeldt, Albert von der Assen, Frank Jacobsen, Till Krech, Rainer H. Krech, Ronald Simon, Christian Bernreuther, Stefan Steurer, Eike Burandt, Niclas C. Blessin
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3175 (2023)
Prognostic markers in routine clinical management of breast cancer are often assessed using RNA-based multi-gene panels that depend on fluctuating tumor purity. Multiplex fluorescence immunohistochemistry (mfIHC) holds the potential for an improved r
Externí odkaz:
https://doaj.org/article/36bff2cc5d55475d8196e9f7dd6cc9c6
Autor:
Maha Elazezy, Katharina Prieske, Lan Kluwe, Leticia Oliveira‐Ferrer, Sven Peine, Volkmar Müller, Linn Woelber, Barbara Schmalfeldt, Klaus Pantel, Simon A. Joosse
Publikováno v:
Molecular Oncology, Vol 15, Iss 12, Pp 3615-3625 (2021)
Methylation of the BRCA1 promoter is an epigenetic gene expression regulator and is frequently observed in ovarian cancer; however, conversion of methylation status is thought to drive disease recurrence. Therefore, longitudinal monitoring of methyla
Externí odkaz:
https://doaj.org/article/d5b14d9287144f21a36580691214ee91
Autor:
Yi Ding, Leticia Oliveira-Ferrer, Eike Vettorazzi, Karen Legler, Karin Milde-Langosch, Linn Woelber, Anna Jaeger, Katharina Prieske, Volkmar Mueller, Barbara Schmalfeldt, Sascha Kuerti
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0269680 (2022)
ObjectiveAt present, maintenance therapy with the antiangiogenic agent bevacizumab or with PARP-inhibitors represent two options for BRCA-wildtype ovarian cancer patients, after platinum-based first line chemotherapy. The identification of molecular
Externí odkaz:
https://doaj.org/article/38c4f26db8f94b77be5d55892a2c84ad
Autor:
Peter Hillemanns, Agnieszka Denecke, Linn Woelber, Gerd Böhmer, Matthias Jentschke, Karoline W. Schjetne, Karsten M.H. Bruins Slot, Agnete B. Fredriksen
Publikováno v:
Clinical Cancer Research. 28:4885-4892
Purpose: To evaluate the safety, immunogenicity and efficacy of a therapeutic DNA vaccine VB10.16, using a unique modular vaccine technology that is based on linking antigens to CCL3L1 targeting module, in women with HPV16-positive high-grade cervica
Autor:
Agnete B. Fredriksen, Karsten M.H. Bruins Slot, Karoline W. Schjetne, Matthias Jentschke, Gerd Böhmer, Linn Woelber, Agnieszka Denecke, Peter Hillemanns
Supplementary Data from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a42f3ff036cc9a0d25a854da0517577
https://doi.org/10.1158/1078-0432.22488869.v1
https://doi.org/10.1158/1078-0432.22488869.v1
Autor:
Agnete B. Fredriksen, Karsten M.H. Bruins Slot, Karoline W. Schjetne, Matthias Jentschke, Gerd Böhmer, Linn Woelber, Agnieszka Denecke, Peter Hillemanns
Supplementary Figure from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b577f3150e3561d23b9021ff2990f0
https://doi.org/10.1158/1078-0432.22488866.v1
https://doi.org/10.1158/1078-0432.22488866.v1
Autor:
Agnete B. Fredriksen, Karsten M.H. Bruins Slot, Karoline W. Schjetne, Matthias Jentschke, Gerd Böhmer, Linn Woelber, Agnieszka Denecke, Peter Hillemanns
Purpose:To evaluate the safety, immunogenicity and efficacy of a therapeutic DNA vaccine VB10.16, using a unique modular vaccine technology that is based on linking antigens to CCL3L1 targeting module, in women with HPV16-positive high-grade cervical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fe19c6dd8e20bd98cea1f4fd0934ce
https://doi.org/10.1158/1078-0432.c.6532823.v1
https://doi.org/10.1158/1078-0432.c.6532823.v1
Autor:
Sophie Fuerst, Thomas Blankenstein, Katharina Prieske, Cordula Petersen, Sven Mahner, Linn Woelber, Mareike Bommert, Hans-Georg Strauss, Matthias W. Beckmann, Nikolaus de Gregorio, Peter Hillemanns, Jalid Sehouli, Klaus Baumann, Severine Iborra, Stefanie Corradini, Felix Hilpert, Anna Jaeger, Alexander Mustea, Christine Eulenburg, Atanas Ignatov
Publikováno v:
Gynecologic Oncology, 164(1), 68-75. ACADEMIC PRESS INC ELSEVIER SCIENCE
Background: The impact of adjuvant radiotherapy (RT) to the vulva with regard to prognosis and local recurrence in patients with vulvar squamous cell cancer (VSCC) is poorly described.Patients and methods: In the AGO-CaRE-1 study 1618 patients with p
Autor:
Sascha Kuerti, I. Fischer, Linn Woelber, J. Dieckmann, S. Reuter, Sabrina Mathey, Eik Vettorazzi, Anna Jaeger, Katharina Prieske, Barbara Schmalfeldt
Publikováno v:
Archives of Gynecology and Obstetrics
Background The value of pelvic lymphadenectomy (LAE) has been subject of discussions since the 1980s. This is mainly due to the fact that the relation between lymph node involvement of the groin and pelvis is poorly understood and therewith the need
Autor:
Katharina Prieske, Monika Hampl, Anna Jaeger, Christine Eulenburg, Barbara Schmalfeldt, Sophie Fürst, Ruediger Klapdor, Sabine Heublein, Paul Gass, Annika Rohner, Ulrich Canzler, Sven Becker, Mareike Bommert, Dirk Bauerschlag, Agnieszka Denecke, Lars Hanker, Dirk Runnebaum, Dirk M Forner, Fabienne Schochter, Linn Woelber
Publikováno v:
Vaginal and vulvar cancer.